AUROPHARMA:NSE
Aurobindo Pharma Ltd
₹1,675.80
arrow_upward
+0.44%(+7.40) 1D
Sep 11, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AUROPHARMA...
Open
₹1,666.70
High
₹1,681.40
Low
₹1,655.50
Mkt. cap
964.22B
Avg. vol.
0.00
Volume
494.25K
P/E ratio
26.18
52-wk high
₹1,717.00
52-wk low
₹1,061.30
EPS
₹64.00
Shares outstanding
585.90M
No. of employees
29K
Open
₹1,666.70
High
₹1,681.40
Low
₹1,655.50
Mkt. cap
964.22B
Avg. vol.
0.00
Volume
494.25K
P/E ratio
26.18
52-wk high
₹1,717.00
52-wk low
₹1,061.30
EPS
₹64.00
Shares outstanding
585.90M
No. of employees
29K
News stories
From web sources and news partners
TipRanks
·
8 hours ago
Aurobindo Pharma to Engage Investors at Kotak Healthcare Forum 2026
TipRanks
·
8 hours ago
Aurobindo Pharma to Join ICICI Securities Investor Meeting on September 17
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29.2K
Founded1986
HeadquartersHyderabad, Andhra Pradesh, India
SectorPharmaceutical industry
Websiteaurobindo.com